8OSQ

Why does the herpes simplex 1 virus-encoded UL49.5 protein fail to inhibit the TAP-dependent antigen presentation?

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H TOCSY	0.4 mM NA- NHSV	90% H2O/10% D2O	50 mM	7.5	1 bar	303	Varian INOVA 500
2	2D 1H-1H NOESY	0.4 mM NA- NHSV	90% H2O/10% D2O	50 mM	7.5	1 bar	303	Varian INOVA 500
3	2D 1H-1H NOESY	0.4 mM NA- NHSV	90% H2O/10% D2O	50 mM	7.5	1 bar	303	Bruker AVANCE 700
4	2D 1H-1H TOCSY	0.4 mM NA- NHSV	90% H2O/10% D2O	50 mM	7.5	1 bar	303	Bruker AVANCE 700
5	2D 1H-1H ROESY	0.4 mM NA- NHSV	90% H2O/10% D2O	50 mM	7.5	1 bar	303	Bruker AVANCE 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	500
2	Bruker	AVANCE	700

NMR Refinement
Method	Details	Software
molecular dynamics	243 restraints were used	Amber

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	10
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VnmrJ	4.3	Agilent Inc.
2	collection	TopSpin	3.5	Bruker Biospin
3	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	data analysis	Sparky		Goddard
5	structure calculation	Amber		Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.